The DEA is increasing its controlled substances quotas for drugmakers for use in treating Covid-19 patients, the agency says in a statement.
- Quotas will be increased by 15% for substances including, fentanyl, morphine, hydromorphone, codeine, ephedrine, pseudoephedrine, and other substances essential to their production: statement
- DEA will also approve increases in imports of medications for patients on ventilators
To contact the reporter on this story:
To contact the editors responsible for this story:
Catherine Dodge, Teaganne Finn
© 2020 Bloomberg L.P. All rights reserved. Used with permission.